NCT01913301View on ClinicalTrials.gov

A Randomized Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure

PHASE2TerminatedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Diastolic Heart Failure
Interventions
DRUG

Alagebrium

Sponsors
All Listed Sponsors
lead

Cardiovascular Clinical Sciences Inc

INDUSTRY

NCT01913301 - A Randomized Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure | Biotech Hunter | Biotech Hunter